Carregant...
A Whole Blood Assay for AR-V7 and AR(v567es) in Prostate Cancer Patients
PURPOSE: The majority of prostate cancer mortality can be attributed to metastatic castration-resistant prostate cancer, an advanced stage which remains incurable despite recent advances. The androgen receptor (AR) signaling axis remains active in CRPC. Recent studies suggest that the expression of...
Guardat en:
| Publicat a: | J Urol |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161406/ https://ncbi.nlm.nih.gov/pubmed/27449259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2016.06.095 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|